CVS Health Short-Term Borrowings decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $2.12B to $0.00. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '22 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.00B | $200.00M | $2.72B | $0.00 | $800.00M | $2.12B | $1.26B | $3.04B | $1.25B | $0.00 |
| QoQ Change | — | — | -80.0% | >999% | -100.0% | — | +164.9% | -40.6% | +141.5% | -59.0% | -100.0% |
| YoY Change | — | — | — | — | -100.0% | — | +959.5% | -53.7% | — | +55.9% | -100.0% |